AliveCor launches AI-enabled Kardia Pro platform in US to help prevent stroke via early detection of atrial fibrillation

AliveCor on Thursday announced the US release of Kardia Pro, which it described as an "industry-first" artificial intelligence (AI)-enabled platform aimed at improving stroke prevention by allowing doctors to monitor patients for early signs of atrial fibrillation. CEO Vic Gundotra said "Kardia Pro tracks important measures of physiology like weight, activity and blood pressure, and, for the first time, AI technology is used to create a personal heart profile for each user, enabling user identification." He suggested the platform allows "patients to be more active participants in their own heart health."

The company also announced that it raised $30 million in new funding, led by investments from Omron Healthcare and the Mayo Clinic, which "will help Kardia Pro become the new standard of care for doctors to enable early detection and prevention of heart disease and stroke." AliveCor added that it will use the additional funds to "accelerate innovations in heart health and continue the rapid expansion of the business."

Omron Healthcare CEO Ranndy Kellogg said his company was "excited to expand our strategic partnership with AliveCor." He indicated that "partnering with AliveCor advances our path forward to build robust software programmes that play a dynamic role in expanding heart health awareness."

In March 2016, AliveCor introduced its Kardia Band, a medical-grade electrocardiogram (ECG) band for Apple Watch that, together with an accompanying smartphone app, lets users "discretely capture their EKG anytime, anywhere." Last September, the company said it would integrate data from Omron Healthcare's Bluetooth-enabled home hypertension devices into its ECG mobile application, marking "the first consumer-ready, clinically validated ECG and blood pressure monitor."

Did you like this article?